Justin Bowers
Stock Analyst at Deutsche Bank
(2.77)
# 2,806
Out of 5,085 analysts
137
Total ratings
49.2%
Success rate
1.9%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTR Avantor | Maintained: Hold | $13 → $17 | $16.69 | +1.86% | 8 | Oct 29, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Buy | $188 → $250 | $214.16 | +16.74% | 9 | Oct 29, 2026 | |
| A Agilent Technologies | Initiated Coverage: Buy | $190 | $181.48 | +4.69% | 1 | Oct 26, 2026 | |
| FTRE Fortrea Holdings | Upgraded: Buy | $20 → $25 | $25.88 | -3.40% | 8 | Oct 15, 2026 | |
| ATR AptarGroup | Initiated Coverage: Buy | $150 | $127.17 | +17.95% | 1 | Oct 7, 2026 | |
| STVN Stevanato Group | Initiated Coverage: Hold | $22 | $19.43 | +13.23% | 1 | Oct 7, 2026 | |
| CRL Charles River Laboratories International | Rated: Buy | $300 → $320 | $373.98 | -14.43% | 13 | Sep 25, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $630 → $720 | $704.15 | +2.25% | 11 | Sep 25, 2026 | |
| CON Concentra Group Holdings Parent | Rated: Buy | $32 → $41 | $40.59 | +1.01% | 3 | Aug 10, 2026 | |
| WAT Waters | Rated: Hold | $350 → $400 | $476.88 | -16.12% | 11 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $430 → $535 | $692.68 | -22.76% | 4 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $270 → $240 | $234.07 | +2.53% | 11 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $66 → $73 | $72.69 | +0.43% | 9 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $6 | $8.50 | -29.41% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $23 | $83.62 | -72.49% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $345 → $315 | $403.64 | -21.96% | 6 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 → $220 | $279.04 | n/a | 16 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $155 → $175 | $184.69 | n/a | 8 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $70 | $122.09 | n/a | 1 | Sep 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $288.79 | n/a | 1 | Jan 17, 2014 |
Avantor
Oct 29, 2026
Maintained: Hold
Price Target: $13 → $17
Current: $16.69
Upside: +1.86%
ICON Public Limited Company
Oct 29, 2026
Maintained: Buy
Price Target: $188 → $250
Current: $214.16
Upside: +16.74%
Agilent Technologies
Oct 26, 2026
Initiated Coverage: Buy
Price Target: $190
Current: $181.48
Upside: +4.69%
Fortrea Holdings
Oct 15, 2026
Upgraded: Buy
Price Target: $20 → $25
Current: $25.88
Upside: -3.40%
AptarGroup
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $150
Current: $127.17
Upside: +17.95%
Stevanato Group
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $22
Current: $19.43
Upside: +13.23%
Charles River Laboratories International
Sep 25, 2026
Rated: Buy
Price Target: $300 → $320
Current: $373.98
Upside: -14.43%
Thermo Fisher Scientific
Sep 25, 2026
Reiterated: Buy
Price Target: $630 → $720
Current: $704.15
Upside: +2.25%
Concentra Group Holdings Parent
Aug 10, 2026
Rated: Buy
Price Target: $32 → $41
Current: $40.59
Upside: +1.01%
Waters
Aug 5, 2026
Rated: Hold
Price Target: $350 → $400
Current: $476.88
Upside: -16.12%
Jul 23, 2026
Reiterated: Hold
Price Target: $430 → $535
Current: $692.68
Upside: -22.76%
Jul 22, 2026
Rated: Buy
Price Target: $270 → $240
Current: $234.07
Upside: +2.53%
Jun 26, 2026
Downgraded: Hold
Price Target: $66 → $73
Current: $72.69
Upside: +0.43%
May 8, 2026
Reiterated: Buy
Price Target: $10 → $6
Current: $8.50
Upside: -29.41%
May 8, 2026
Reiterated: Hold
Price Target: $17 → $23
Current: $83.62
Upside: -72.49%
Feb 13, 2026
Reiterated: Buy
Price Target: $345 → $315
Current: $403.64
Upside: -21.96%
Jul 29, 2025
Reiterated: Buy
Price Target: $260 → $220
Current: $279.04
Upside: n/a
Aug 16, 2024
Reiterated: Buy
Price Target: $155 → $175
Current: $184.69
Upside: n/a
Sep 16, 2019
Initiated Coverage: Hold
Price Target: $70
Current: $122.09
Upside: n/a
Jan 17, 2014
Reiterated: Buy
Price Target: $140
Current: $288.79
Upside: n/a